
A Case For Paying Allogeneic Cell Therapy Product Donors
By Jennifer Chain, Ph.D., CABP, cellular starting material expert, and Stephen McClung, MBA, plasma center operations expert For over 80 years, the world has quietly built two parallel blood supply ecosystems. The first, rooted in the non-compensated donor …